Medicine

Targeting TGF-β Signaling in Cancer.

S. Çolak, P. ten Dijke

2017TRENDS IN CANCER

DOI: 10.1016/j.trecan.2016.11.008

tlooto サマリー

The rationale for targeting TGF-β signaling in cancer is reviewed, the clinical status of pharmacological inhibitors are summarized, and the direct effects of TGF -β signaling blockade on tumor and stromal cells are discussed.

要旨

要旨は利用できません。

引用形式

ÇOLAK, S.; DIJKE, P. ten. Targeting TGF-β signaling in cancer. TRENDS IN CANCER, 2017, 3 1: 56–71.